Metastatic Prostate Cancer incidence and prostate-specific antigen testing: new insights from the European Randomized Study of Screening for Prostate Cancer

BACKGROUND: The European Randomized study of Screening for Prostate Cancer (ERSPC) has shown a 21% reduction in prostate cancer (PC) mortality and a 1·6-fold increase in PC incidence with PSA-based screening (at 13 years of follow-up). We evaluated PC incidence by risk category at diagnosis across t...

詳細記述

保存先:
書誌詳細
出版年:Eur Urol
主要な著者: Buzzoni, Carlotta, Auvinen, Anssi, Roobol, Monique J, Carlsson, Sigrid, Moss, Sue M, Puliti, Donella, de Koning, Harry J, Bangma, Chris H, Denis, Louis J, Kwiatkowski, Maciej, Lujan, Marcos, Nelen, Vera, Paez, Alvaro, Randazzo, Marco, Rebillard, Xavier, Tammela T, Teuvo LJ, Villers, Arnauld, Hugosson, Jonas, Schröder, Fritz H, Zappa, Marco
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982869/
https://ncbi.nlm.nih.gov/pubmed/25791513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2015.02.042
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料